Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report. In a recent report released on January 16th, 2024, KLAS Research showcased Medicom alongside other healthcare IT vendors across various market segments. KLAS Research conducts annual interviews with healthcare […]
Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVI™ (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting. AMTAGVI is the first individualized Tumor Infiltrating Lymphocyte (TIL) therapy […]
China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI
China Medical University Hospital (CMUH) in Taiwan announced its collaboration with Google Cloud in mid-December 2023. Using Google Cloud’s generative AI technology, including MedLM, which is a large language model built on Med-PaLM 2, CMUH has developed a comprehensive “AI-assisted Physician” system which aims to assist healthcare professionals in disease diagnosis, treatment planning, patient education, and […]
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor
Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received approval of registrational phase III clinical trial of the combination therapy between its novel KRAS G12C inhibitor glecirasib and novel SHP2 inhibitor JAB-3312. JAB-3312 is the first SHP2 inhibitor entered into phase III study globally in combination with KRAS […]
6th National Conference on Tobacco or Health Convenes in Delhi
With India battling a staggering toll of over 1 million deaths annually due to tobacco use, the nation is gearing up for an ‘audacious race against time’ to become tobacco-free. The 6th National Conference on Tobacco or Health, themed “Towards Tobacco-Free India – An Audacious Race Against Time” will serve […]
New clinical trial shows that algae-based omega-3 lecithin AlmegaPL® provides better cardiovascular health support compared to traditional omega-3 fish oils
Qualitas Health, LLC (dba iwi life) The results of a new clinical trial show evidence that the microalgae-derived AlmegaPL®, the foundational ingredient produced by iwi life™, delivers clinically relevant results decreasing triglycerides by 14% and remnant cholesterol such as very-low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) by up to 25%.1,2 “This marks […]
St. Elizabeth Healthcare First in Kentucky to Implant New Device To Treat Abnormal Heart Rhythm
Doctors with the Florence Wormald Heart & Vascular Institute at St. Elizabeth Healthcare are the first in Kentucky and the Greater Cincinnati region to implant the Aurora EV-ICD™ system — a new device to treat fast or irregular heartbeats and prevent sudden cardiac arrest. J. Christian Hays, MD, Director of Cardiac Electrophysiology at St. Elizabeth Healthcare, performed the […]
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with […]
Dragonfly Announces Clinical Collaboration Exploring Combinations Between Dragonfly’s DF1001 HER-2 TriNKET® and Gilead’s Trodelvy® in Two Cancer Indications
Dragonfly Therapeutics, Inc., a clinical-stage biotechnology company developing novel immunotherapies, today announced a new clinical collaboration designed to evaluate and combine DF1001, a HER-2 immune activating device developed using Dragonfly’s TriNKET technology platform and Dragonfly’s lead clinical asset, with Trodelvy, Gilead’s Trop-2-directed antibody-drug conjugate in metastatic breast cancer and non-small […]
WellBiz Brands Inc. Names Franchise Industry Veteran Amanda Clark as CEO
WellBiz Brands Inc. (“WellBiz Brands”), the pre-eminent beauty and wellness franchise platform, today announced that Amanda Clark, a seasoned franchise industry executive, has been appointed Chief Executive Officer, effective March 12, 2024. Ms. Clark succeeds Jeremy Morgan, who will transition from the business after seven years leading the company. Under Mr. Morgan’s leadership, WellBiz Brands successfully […]
